s
COMUNICATO STAMPA SPONSORIZZATO – The World’s First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
06-11-2025, 00:00
(Immediapress) – CorrectSequence Therapeutics’ CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 5, 2025 /PRNewswire/ — On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, announced that the first patient in its Investigator-Initiated Trial (IIT) of the […] L'articolo COMUNICATO STAMPA SPONSORIZZATO – The World’s First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia proviene da La Ragione.
CONTINUA A LEGGERE
12
0
0
Guarda anche
La Ragione
Ieri, 20:57
Attesa super tempesta di neve a New York: cancellati oltre mille voli
La Ragione
Ieri, 20:52
Zelensky in Canada: “Per la ricostruzione servono 800 miliardi di dollari”
La Ragione
Ieri, 20:27
Napoli, 18enne accoltellato a Chiaia: si costituiscono due minorenni
La Ragione
Ieri, 19:49
Grazie e auguri
La Ragione
Ieri, 18:36
Federica Brignone torna in pista: l’allenamento a Courmayeur
La Ragione
Ieri, 15:57